Loading company…
Quotient Suisse develops in-vitro diagnostic products for autoimmune diseases and allergies.
Founded in 2007 and based in Eysins, Switzerland, Quotient Suisse develops diagnostic products for autoimmune diseases and allergies. Its portfolio includes the MosaiQ platform, LumiQ solution, and Alba reagent line. The company raised USD 96.6 million in a private placement in November 2019.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in